Key terms
About CVRX
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other Countries geographical segments. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CVRX news
May 16
7:36am ET
CVRx appoints Adamson as CMO, announces senior leadership team hires
May 01
11:08am ET
Piper Sandler Remains a Buy on CVRx (CVRX)
May 01
11:07am ET
CVRx price target lowered to $15 from $33 at Piper Sandler
May 01
9:41am ET
CVRx Inc trading resumes
May 01
9:36am ET
CVRx Inc trading halted, volatility trading pause
May 01
9:10am ET
CVRx assumed with a Buy at Craig-Hallum
May 01
8:51am ET
CVRx price target lowered to $18 from $35 at Lake Street
May 01
8:29am ET
CVRx price target lowered to $14 from $32 at Canaccord
May 01
7:07am ET
William Blair downgrades CVRx after ‘awkward and surprising’ miss
May 01
4:56am ET
CVRx downgraded to Market Perform from Outperform at William Blair
May 01
4:36am ET
CVRx downgraded to Neutral from Overweight at JPMorgan
Apr 30
4:36pm ET
CVRx Awards Bonus for Key Role in Management Transition
Apr 30
4:15pm ET
CVRx Sees FY24 revenue $$50M-$53M, consensus $55.21M
Apr 30
4:13pm ET
CVRx sees Q2 revenue $11.3M-$12.3M , consensus $13.12M
Apr 30
4:11pm ET
CVRx reports Q1 EPS ($1.04), consensus (54c)
Apr 24
9:00am ET
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL) and CVRx (CVRX)
Apr 15
7:34am ET
CVRx announces additional data supporting long-term benefits of barostim
CVRX Financials
Key terms
Ad Feedback
CVRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CVRX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
